Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.

Wei L, Clauser E, Alhenc-Gelas F, Corvol P.

J Biol Chem. 1992 Jul 5;267(19):13398-405.

2.

The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.

Wei L, Alhenc-Gelas F, Corvol P, Clauser E.

J Biol Chem. 1991 May 15;266(14):9002-8.

3.

Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.

Binevski PV, Sizova EA, Pozdnev VF, Kost OA.

FEBS Lett. 2003 Aug 28;550(1-3):84-8.

5.

A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.

Andújar-Sánchez M, Cámara-Artigas A, Jara-Pérez V.

Biophys Chem. 2004 Oct 1;111(2):183-9.

PMID:
15381315
6.

Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.

Fernandez M, Liu X, Wouters MA, Heyberger S, Husain A.

J Biol Chem. 2001 Feb 16;276(7):4998-5004. Epub 2000 Nov 6.

7.
8.

Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.

Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, Alhenc-Gelas F.

J Biol Chem. 1994 Oct 28;269(43):26806-14.

9.

Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins.

Bevilacqua M, Vago T, Rogolino A, Conci F, Santoli E, Norbiato G.

J Cardiovasc Pharmacol. 1996 Oct;28(4):494-9.

PMID:
8891872
10.

Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.

Natesh R, Schwager SL, Evans HR, Sturrock ED, Acharya KR.

Biochemistry. 2004 Jul 13;43(27):8718-24.

PMID:
15236580
11.

Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.

Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA.

Biochemistry (Mosc). 1999 Aug;64(8):938-44.

PMID:
10498812
12.
13.

Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.

Udupa EG, Rao NM.

Indian J Biochem Biophys. 1997 Dec;34(6):524-8.

PMID:
9594434
14.

Identification of two active site residues in human angiotensin I-converting enzyme.

Williams TA, Corvol P, Soubrier F.

J Biol Chem. 1994 Nov 25;269(47):29430-4.

16.

Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.

Skirgello OE, Balyasnikova IV, Binevski PV, Sun ZL, Baskin II, Palyulin VA, Nesterovitch AB, Albrecht RF 2nd, Kost OA, Danilov SM.

Biochemistry. 2006 Apr 18;45(15):4831-47.

PMID:
16605251
18.

Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.

Ceconi C, Francolini G, Olivares A, Comini L, Bachetti T, Ferrari R.

Eur J Pharmacol. 2007 Dec 22;577(1-3):1-6. Epub 2007 Aug 3.

PMID:
17716647
19.

Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture.

Andrade MC, Quinto BM, Carmona AK, Ribas OS, Boim MA, Schor N, Casarini DE.

J Hypertens. 1998 Dec;16(12 Pt 2):2063-74.

PMID:
9886898
20.

Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.

Georgiadis D, Cuniasse P, Cotton J, Yiotakis A, Dive V.

Biochemistry. 2004 Jun 29;43(25):8048-54.

PMID:
15209500

Supplemental Content

Support Center